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Independent clones of mouse kera~inocytes initiate.d in lJit~o 
ave rise to tumor phenotypes typical of mouse skin multl-
gtage carcinogenesis and histologically similar to human ~umors of the skin, and head and neck. High - molecular-
weight genomic DNAs isolated from two 7,12-
dimethylbenz[a ]anthracene (DMBA) - initiated murine 
epithelial carcinoma cell lin~s and .o?e papilloma ~ell .line 
ere examined for transformll1g activity by transfectlOn mto ~IH3T3 cells. DN~s from each?f these c~llline.s resul~e~ in 
the formation of foCi morphologically ~nlIke foCi contamll~g 
n activated c-Ha-ras oncogene. Followmg polymerase cham 
:eaction amplification. of the c-J:Ia-ra~ gene, .Xba I r~st.ric­
tion analysis and oligonucleotide differential hybndlza-
C linical observations and esta~ lished experimental. an-imal systems support a multi-step model of carCIno-genesis [1,2] . Mutational activation of the c-Ha-ras gene has been implicated in the development of both human and rodent epidermal tumors [3 ,4]. In the 
twO-stage model of mouse carcinogenesis, not only is the f~e9~e,:cy 
of c-Ha-ras mutation high [5], but it is proposed to be a ~ mltlatlon 
event [6-8]. In contrast, c-Ha-ras mutations ar~ a relatively mfre-
uent event in human epidermal carcll1ogenesls. Brown el af re-
\rted that 100% of 7,12-dimethylbenz[a]anthracene (DMBA)-~tiated mouse papillomas possess codon 61 mutations [5], and yet ~nly 10% of these papillomas wi.1I progress to malignant carcinomas 
[9]. Severallin~s of ev.,dence l11d,~ate that the f:equency of ra~ muta-
tions is lower 111 malignant carClllomas than 111 be11lgn papillomas 
[5, 10]. Because carcinomas are thought to arise from pre-existing 
papillomas, these obser:'atlons could ll~dlcate that c-~a-ras mu~a­
tions are lost during malignant progressIOn, or that carCll10mas anse 
at a higher frequency fro.m. ~apillomas thatdo not contain a c-Ha-r~s 
mutation. The first pOSSIbility contrasts With most models of carcI-
nogenesis whereby progression is proposed to occur through the 
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tion did not detect 61st, 12th, or 13th codon mutations. 
Southern and Northern analysis confirmed that the normal 
c-Ha-ras gene was not activated by amplification or overex-
pression. These results provide evidence that 7, 12-dimethyl-
benz[a ]anthracene-induced malignant transformation of 
murine keratinocytes occurred independent of point muta-
tions associated with c-Ha-ras activation. The absence of an 
activated c-Ha-ras oncogene in these cell lines distinguishes 
our model from other mouse models of carcinogenesis and 
may provide a model for functional genetic changes during 
initiation and progression of human epithelial cancers. Key 
words: oncogene/DMBA/ epidermalj carcinogenesis.] bwest 
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clonal selection and retention of genetic events required for tumori-
genesis. However, in support of the second prediction, several stud-
ies report that ras mutations correlate better with tumor growth or 
differentiation than with malignancy [10,11]. Furthermore, the ab-
sence of c-Ha-ras mutations in the majority of human tumors of the 
epidermis and head and neck epithelia [12-14] suggest that, in 
contrast to mouse skin, human skin carcinogenesis proceeds pre-
dominately through a ras-independent pathway. The predominance 
of c-Ha-ras mutations in mouse papillomas may be a result of the 
acute exposure to a potent carcinogen. Whereas exposure to envi-
ronmental carcinogens is an established risk factor in human carci-
nogenesis, most human epithelia cancers may be the result of 
chronic exposure to weak carcinogens. 
The present report demonstrates that cloned mouse cells initiated 
with DMBA ill vi tro generate benign and malignant tumorigenic 
phenotypes very similar to human squamous cell tumors. In addi-
tion, they are indistinguishable fr0111 mouse epidermal tumors pro-
duced during ill villo two-stage carcinogenesis with DMBA and 
12-0-tetradecanylphorbol-13-acetate (TP A) treatments. Because 
th~re is no evidence for activation of the H a-ras proto-oncogene, 
tim cloned keratll10cyte model may be useful for the identification 
of gene targets more pertinent to human skin carcinogenesis, as well 
as for functional studies of ras gene activation at discrete stages of 
carcinogenesis. 
MATERLALS AND METHODS 
Cell Lines Keratinocytc cell strain 29 1 was derivcd from neo-natal Balb/c 
Ros epidermis [15]. As described previously [16] , these cells were treated for 
24 h with 0.2 - 0.4 jiM DMBA in the presence of 10 ng/ml epidermal 
growth factor (EGF) and 10% dermal-fibroblast -conditioned medium. Pu-
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T a ble I. NIH3T3 DNA Transfectio ns" 
Genomic DNA Total Foci T o tal D ishes T otal Jig Foci/ Jig 
Mock 3' 13 
N IH 3T3 0 13 120 0.0 
carB 105 14 97.5 1.07 
291 12 2 1 142.5 0.08 
291.09RAT 11 ' 9 54 0.20 
291.03RAT 62 21 142.5 0.43 
291.05RAT 67 18 157.5 0.42 
• Mock transfections contain ing no DNA and NI H3T3 DNA into NIH3T 3 cells 
served as nega tive contro ls. Geno mic D N A containing an activated c-Ha-ras o ncogene, 
carB, served as the posi tive control. Eighteen hOllrs after transfcction, plates were split 
and maintained in DMEM 5% calfse rum for 28 d, at which time foc i were scored. Data 
arc the cumulative result of three independent experiments except w here noted. 
' T otal resu lts from two experiments. 
' Total resu lts [rom one experiment. 
tatively initi ated clones, 291.09, 291.03, and 291.05, were selected by their 
abili ty to escape te rminal differentiation induced by increased extracellular 
ca lcium concentra tions [1 6,1 7]. The ce ll lineage derived from clone 29 1.09 
has been tested for response to the tumor pro moter TPA, confirming its 
initiated cell phenotype [1 8]. The frequency and stability of tumor form a-
tion fro m the initiated ce ll lineages have been reported [16,18, 19]. 
T umor Induction a nd Histology C ultured ce lls we re harvested and 
inoculated in to ath ymic nu/ nu mice by skin grafting as previously described 
[1 6]. Female ath ymic nu/nu mice w ith Balb/c background were obtained at 
4-5 weeks of age from H arl an Sprague Dawley, Indianapolis, IN. When 
tumors were 5 - 1 0 mm in diameter, they were harvested, fi xed in fo rmalin, 
embedded in pa raffin , sectioned, and sta ined w ith hematoxylin and eosin 
[1 9]. 
DNA T ransfections into NIH3T3 Fibroblasts Low-passage (PI2-14) 
NIH 3T3 fibroblasts were used as the recipient of genomic DNA isolated as 
previously described [20] from non-tumorigenic, benign, or malignant cell 
lines. NII-I 3T3 cul tures were seeded at a density of 1 X 1 D· ce lls/plate 24 h 
prio r to transfection. T ransfec tion assays were performed by the ca lcium 
phosphate co-prec ipitation method [21] . Mock transfections containing no 
DNA and N II-I3T 3 D N A into NII-I3T 3 cel ls served as nega tive controls. 
CarB genomic D N A [22], w hich contains an activated c-!-I a-ras oncogene, 
served as the pos itive contro l. Eighteen hours after transfection, cell s were 
tryps inized and rep lated at 25% their original de nsity. C ultures were main-
tained in DMEM conta ining 5% fetal bovine serum , and plates were scored 
for morphologic transformation 21 - 28 dafter transfection. 
PCR of c-Ha-ras and X ba I Restriction Analysis Tota l genomic ON A 
was iso lated from confluent cul ture in 100-mm dishes of each cell line as 
previously described [20] . Polymerase chain rcaction (PCR) primers (29-
IIl crs, U S- RAS 5' GAGAGAATTCCCGCTGTAGAAGCTATGAC 3', 
DS-RAS 5' CACAGAA TTCACGGAAGCTTCCT CACG 3') for the am-
plification of a 588-bp band corresponding to exons one and two of the 
genomic c-!-Ia-ras gene were synthesized on an Applied Biosystems 391 
DNA synthes ize r. Amplifica tion conditions were as fo llows: a 20-Jll reac-
tion mixtu re contained 1 Ji g of genomic DNA , 10 mM Tris-C I, pH 8.3, 
1.5 mM MgCI2, 50 mM KC l, 0 .1 mg/ml gelatin, 1 JIM of each primer, 
200 JIM dNTPs, and 5 uni ts of Taq D N A polymerase (Boehringcr Mann-
heim, Ind ianapo lis, IN) . Each reaction mixture was overl aid with 20 Jll of 
mineral o il and D NA was denaturcd at 95'C for 5 min. Amplification was 
performed fo r 30 cycles with 1 min at 95 'C for denaturation, 1 min at 63 'C 
for an nealing, and 1 min at 72'C for primer ex tension. Fo llowing amplifi-
cation, th e reaction mixture was ex tracted once with chloroform , and 5 JlI 
were transferred to a 20-JlI digestion reaction for X ba I restriction. PC R 
products were anal yzed by 1.5% agarose gel electrophoresis. Restri ction 
fragments obta ined by cleavage of pBR322 w ith either Bst NI or Msp I wcre 
used as size standards. 
PCR of c-Ha-ras and Discriminative Oligonucleotide Dot Blot 
H ybridization Tot,,1 genomic DNA was isolated from a conflucnt 60-
mm cul ture di sh of each cell line as described [23]. PCR primers fo r the 
amplificat ion of murine Ha-ras codon 61 or 12 and 13 were obtained from 
C ion tech Labora tori es (Palo Alto, C Al or provided by M. Schwarz (Heidel-
berg, Germany). Amplification cond itions were chosen as fo llows. A 100-JLl 
reaction mixture contained 1 JI of genomic D NA in 10 mM Tris-CI, pH 8.3, 
50 mM KC l, 1.5 mM MgCI2' 0.001 % ge latin , 1 JIM of each primer, and 
200 JIM dNT Ps. Reaction mixtures wcre overl aid wi th 90 JlI mineral o il , 
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and denatured at 95 ' c for 5 min. Subsequently, two units ofT aq polym erase 
(Perkin Elmer/Cetus) were added , and the primers were allowed to anneal at 
45'C. Thermai cycling was performed for 35 rounds with 1.0 min an d at 
95 'C fo r denaturation, 1.0 min at 45 ' c for primer annea ling, and 1.5 min at 
72 ' C for primer ex tension. PCR products were analyzed by 2% agarose gel 
electrophoresis w ith size marke rs (rest riction fragments obtained by cleav_ 
age of 0XI 74-DNA with !-lac III) . 
Equal amounts of the amplified DNAs were spotted onto nylon m em_ 
branes (Biotrace RP, Gelman) and the DNA was fi xed by bak ing fo r 2 h at 
80 'C. M embranes were prehybridized for 4 h at 50 'C in a mixture of 
5 X SSPE, 0.3% sodium dodecylsulfate (SDS), and 500 mg sonicated her_ 
ring sperm DN A and subsequently hybridized fo r 18 h in the same miXture 
with either the 32P-end-labeled 20- mer o ligonucleotide for the wild type 
sequence or the 20-mcrs modified in base 1, 2, or 3 of codons 12, 13, or 61 
[5]. Afte r hybridization, thc membranes were washed twice in 2 X SSPE and 
0.1 % SDS for 30 min at roo m temperature fo llowed by stringent wash es in 
5 X SSPE and 0.1 % SDS fo r 10 min at selec tive discriminating temperatures 
(58 - 68'C). Subsequently, the membranes were exposed to Kodak X-O m at 
films at - 80 'C using intensify ing screens. 
Southern Analysis Twenty micrograms of genomic DNA from kerati_ 
nocy te cell lines o r NI!-I3T 3 cell primary tra nsfec tants were digested With 
Eco RI , resolved by 1 % aga rose gel electrophoresis, and transferred to G e n e_ 
Scrccllnylon membranes (New England Nuclear, Bos ton, MA) according to 
manufacturer's instructions. DNA was UV-linkcd to the membranes using a 
Stratalinker (Stratagcne, La Jo lla, C Al . Membranes were incubatcd over. 
night at 42 'C in a solution of 50% formam ide, 10 X Denhardt 's so lution 
50 mM Tris-C l (pH 7.5), 0.1 % sodium pyrophosphate, 1 % 50S, 1 M N aC!' 
10% dextran sul fa te, and 200 Jlg/ml D N A from salmon testes . Rando~ 
priming (US Biochemica ls, C leve land , O H) waS used to 32P-label a c-Ha- ras 
(a 600-bp Eco RI-Bam !-II fragment of p65GE9EB2 [20]) probe to a final 
spec ific acti vity of 2 - 4 X 1 D· cpm/ ml. After 24 h of hybrid ization at 42 'c 
membrancs were washed tw ice with 2 X SSC at room temperature fo r 5 
min, twice with 2 X SSC and 1 % SDS at 65 'C for 30 min , and twice with 
0. 1 X SSC at room temperature for 30 min . Membranes were exposed to 
Kodak X-Omat films at -80 'C using intensifying screens . 
Northern Analysis Cells were harvcsted when approx imately 70 - 100% 
confluent. RNA was isolated by guanidinium/cesiulll chlo ride ex tractiOn 
and dissolved in dicth ylpyrocarbonate- rrcated watcr for N orthcrn blot anal . 
ys is as described previously [24]. T cn micrograms of total cellular RNA were 
reso lvcd by 1.2% aga rose ge l electrophoresis, transferred to a nylon m eru. 
brane, and hybridized with a n p-Iabeled Ha-ras probe (830-bp !-lind II! 
fragment of !-Ia-MuSv [25]). An 840-bp Eco RI-Sal I fragment of pA6 [26] 
was used fo r 7S RNA detection, which se rved as an internal control for R NA 
loading. Probes were labeled with n p dTTP by the random primer method 
using a multiprime DNA labelin g kit (Amersham, Arlington !-Ieights, IL). 
32P-labcled probe was used at the final concentration of 1- 2 X 106 cpm/ru!. 
Quantitation of rela tive amounts of RNA was done by densitometry of 
exposed films using a Quick Scan (!-Ielena Laboratory, Beaumont, TX) and 
Fastsca n computing densitometer (Molecu lar Dynamics, Sunnyvale, CAl. 
T he c-Ha-ras hybridization signals were compared after adjustment for dif. 
ferences in 7S RNA. 
RESULTS 
The m o rph o logy of initia ted and tumorigenic epidermal cells under 
LC conditions w as indistin guish able from that o f g rowing paren tal 
ce ll s (F ig 1A - C compared to D) , with th e exccption t hat 
29 1.03 RAT, a poorl y diffcrentiated squam o us ce ll carc ino m a line, 
te nded to di splay p o lar ex tc nsio ns (Fi g 1 C). C h aracteristi call y [15-
17] , tumo r cells continued to m aintain a pro life ra tive subpo pul atiou 
upo n exposure to m edium containing 1.4 mM Ca++ (Fig IE-G) 
whereas pare ntal ce ll s unde rwent terminal differe ntiatio n (Fig 1H). 
B ecause epith elia l cell s stratify and k eratiniz ing tumo r cells grow 
poorly in so ft agar, th ere are no m o rpho logic correlates of m alig-
nancy ill Il il ro fo r epith e lia l ce ll s as th ere a re for fibrob last cell 
m od els. There fo re, histopatho logy of ill Ili va tumors w as utilized to 
ass ig n stages o f m ali g nancy . As sho wn in Fi g lI - K, cell line 
291.09RA T (Fi g 11) pro duced well-differentia ted beni gn papillo. 
m as, 29 1.0SRAT (Fi g 1.n moderate ly differe nt iated squamous car-
cino m as, and 291.03RA T poorl y diffe rentia ted carcino m as a t skin 
g raft sites (Fig lK) and in m etastases to the lun g (Fi g IL) . 
DMBA h as bee n prev io usly show n to consiste ntly induce c-Ha-
ras ac tiva tio n in both papillo m as a nd carcino mas o f th e epider mi • 
w hic h is d e tectable as trans fo rmin g acti v ity in the NIH3T3 focus-
fo rmatio n assay [7] . T o tes t w h ethe r th e tumo r ce ll s o f o ur keratino-
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Figure 1. III virro morphology of tumor cc1llines compared to pa re nt~ l cell 
strain and tumor histopathology. Cells were cultured under LC conditions 
co nd u cive to normal kera tinocytc pro liferation ([A] 291.09RAT; [B] 
29 1.0SRAT; [C] 29 t.03RAT; and [D] 291 ) or under HC conditions that 
permitted tumor cell growth ([E] 291.09RAT; [FJ 29 1.0SRAT; and [G] 
29 1.03RAT) but induced term inal differentiation of normal cells ([H] 29 1) . 
Micrographs of tumor cel ls depict hematoxylin-and-eosin -stained sections 
of rumors obtained by skin grafting ([T] 291.09RA T; UJ 29 1.05RAT; [K] and 
[L]29 1.03RAT) . Tumors were from skin except [LJ . which depicts a lung 
metast asis of29 t.03RAT . Bars, 125 ,um(A-H). 100pm(J). 120pm(j). and 
60 j.LM (K,L). 
cyte model had similar focus-forming activity, we examined the 
high molecular weight genomic DNAs Isolated from all the cell 
lines (Table I) . N o highly refractile, disorganized foci typical of 
dominant H a-ras-transforming activity were present in cells trans-
fected with epidermal cellular DNA in comparison to the carB 
positive controls (Fig 2). The carB cell line was derived from a 
DMBA/ TPA-induced squamous cell carcinoma and is known to 
contain a homozygous 61st codon A to T transversion [22]. How-
ever, atypical foci were detected in all of the epidermal lines tested. 
Genomic DNA from eac h carcinoma cell line, 291.05RAT and 
291.03RA T, formed foci at fivefold higher frequencies than 291 
genomic DNA. Genomic DNA for the benipn pap!lloma-forming 
cell line 291.09RA T generated focI at a 2.5 times higher frequency 
than the non-tumorigenic line. These results correlate well with th e 
in vivo tumorigenicity data. 
A more direct search for point mutations in the frequently mu-
tated codons 12, 13 , and 61 of the c-Ha- ras proto-oncogene was 
carried out using the peR technique. As shown in Fig 3A, DNA 
from the carB-positive control of NIH3T3 foci contained the ex-
pected Xba I restriction fragment-len gth ~olymorphism (RFLP) 
indicative of the trans fer of c-Ha-ras gene with a 61st codon A to T 
transversion. In contrast, PeR-amplified DNAs fro m the Ilon-tu-
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Figure 2. Morphology of NIH3T3 ce ll foci induced by transfection of 
genomic DNAs. Passage rwe1ve NIH 3T3 fibroblasts were used as the recip i-
ent of genomic DNA isolated from non-tumorigenic, beni gn, or malignant 
cells. Mock transfections containing no DNA and transfection of carB 
DNA, which contains an acti vated c-Ha- ras, were used as negative and 
positive controls, respectively. Transfected fibroblasts were main tained for 
21 din DMEM contain ing 5% ca lf serum. Pictured arc a portion of a highly 
refractile representative c-Ha-ras-positive carB focus (A), a non-ras 
29 1.05RA T focus (B). a non-ras 291. 03 RAT focus (C), and a background of 
confluent NIH3T3 ce lls (D) . Bar - 75 pm. 
morigenic 291, the papi lloma 291.09RAT, and the squamous cell 
carcinoma 291.05RA T and 291.03RA T cell lines were not sensi tive 
to restriction by Xba 1. Likewise, individual NIH3T3 cell foci from 
the carcinoma cell DNA transfections did not contain the Xba I 
RFLP (data not shown) . Point mutations in the 12th, 61st (Fig 3B), 
and 13th codons (data not shown) were ruled out by peR amplifi-
cation and dot blot hybridi zation of PCR products with sequence-
specific oligonucleotide probes. 
In the absence of codon mutations associated with activation, 
c-Ha-ras activation can occur by either gene amplification or over-
expression [7,27,28]. Southern analysis indicated no amplification 
of the c-Ha-ras gene in th e non-tumorigenic, benign, or malignant 
carcinoma cell lines (data not shown). Furthermore, there was no 
detectabl e difference between carcinomas and parental epidermal 
cells in the number of copies of the c-Ha-ras allele in the foci derived 
from high molecular weight DNAs. Northern analysis indicated 
that the abundance of c-Ha-ras mRNA was similar among the be-
nign and malignant tumor cell lines and th e 291 parental cel ls 
(Fig 4) . 
DISCUSSION 
Experimental animal systems and ill lIilro transformation assays de-
signed to simulate human carcinogenesis have helped to provide 
both a functIOnal and temporal framework for the operational 
model of multi-stage carcinogenesis. These systems have been used 
to identify chemically induced gain-of-function mutations in cellu-
lar proto-oncogenes. The NIH3T3 transformation assay has been 
particularly efficient in detecting mutated c-Ha- ras, one of the most 
extensively studied oncogenes to date in both rodent and human 
tumors [3 ,4,29 - 31]. Analysis of foc i formed in this assay frequently 
correlates dominant transforming activity with the transfer of a 
c-Ha-ras oncogene mutated at th e 12th , 13th, or 61st codons. 
The laboratories of Barbacid [6], Balmain [5,30], and Bowden 
[20] have identified carcinogen-specific ras mutations in tumors 
derived by initiation/ promotion protocols. In the mouse skin rwo-
stage initiation/ promotion model, DM.BA can act either as a potent 
complete carcinogen or as an initiator inducing heterogeneous pop-
ulations of beni gn papillomas wi th varying potential to progress to 
malignancy [5 ,32]. These data and the discovery that the v-Ha-ras 
oncogene can replace chemical initiation have led to th e proposal 
that c-Ha-ras mutations may be coincident with initiation in mouse 
skin [33,34]. 
The data presented here demonstrate that DMBA can malig-
nantly transform mouse keratinocytes independent of point muta-
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Figure 3. (A) PCR-RFLP analysis for putative A 182 to T transversion in the 
61st codon of c-Ha-ras. A 588-bp fragment containing the 61st codon of 
c-Ha- ras was amplified, subjected to Xba I digestion, resolved by 1.5% 
agarose gel electrophoresis, and stained with ethidium bromide. pBR322 
DNA digested with Bst NI or Msp I was used as size standards. SlIIal/ 
arrowheads, positions of the uncut, 588-bp fragment, and the Xba I fragments 
diagnostic of a 61st codon mutation, 414 bp and 174 bp. (B) Differential 
oligonucl eotide hybridiza tion for the detection of putative mutations in 
codons t 2 and 61 of c-Ha-ras. PCR-amplified DNAs containing codons 12 
or 61 were spotted onto nylon membranes and subjected to differential 
oligonucleotide hybridization as described in Materials a"d Methods. Left, 
hybridization with oligonucleotides containing substituted nucleotides in 
codon 61. Amplified DNAs were spotted in the followin g order: l a, normal 
murine epidermis; Ib, line carB; lc, strain 291; Id, line 291.03RAT; Ie, line 
291.05RAT; If, line 291.09RAT; 2a, heterozygous mouse tumor with C I81 
to A transversion; 2b, heterozygous mouse tumor with A 182 to T transver-
sion; 2c, heterozygous mouse tumor with A 182 to G transition; 2d, heterozy-
gous mouse tumor with A 183 to T transversion; and 2e, amplification with-
out genomic DNA. Hybridizations were carried out with oligonucleotides 
specific for the wild type sequence CAA of codon 61 or the mutated se-
quences AAA, CTA,CGA, and CAT. Right, hybridization with oligonu-
cleotides containing substituted nucleotides in codon 12. Amplified DNAs 
1a- 1 f were spotted in the same order as seen on the left side. 2a, heterozygous 
mouse tumor with G" to A transition; 2b, heterozygous mouse tumor with 
G34 to A transition; 2c, heterozygous mouse tumor with G34 to T transver-
sion; and 2d, amplification without genomic DNA. Hybridizations were 
carried out with oligonucleotides specific for the wild-type sequence GGA 
of codon 12 or the mutated sequences AGA, GAA, GTA, and GCA. 
tions associated with c-Ha-ras activation. The data from the 
NIH3T3 focus-formation assay indicate that these cell lines possess 
dominant transforming activity. However, oligonucleotide dot blot 
analysis of peR amplification products indicated that c-Ha-ras was 
not mutated in the 12th, 13th, or 61st codons. Whereas genomic 
DNA amplification of the c-Ha-ras oncogene or elevated c-Ha-ras 
steady-state mRNA levels are often indicative of activation of the 
c-Ha-ras gene [7 ,27,78] , the data presented here indicate that nei-
ther of these mechanisms can account for the dominant transform-
ing activity detected in the NIH3T3 assay. Like the majority of 
human basal cell and squamous cell carcinomas [1 2-14], these be-
nign and malignant mouse cell lines appear to have originated inde-
pendent of c-Has-ras mutation. , 
The majority of human tumors are of epithelial origin. Whereas 
most attempts to simulate human epithelial carcinogenesis irl vitro 
have met with difficulties, the use of rodent model systems has 
alleviated some of these difficulties and helped to elucidate the role 
of oncogene activation in carcinogenesis [5 ,20,31] . However, 
human epithelial neoplasms may contain a different spectrum of 
activated oncogenes than mouse skin [1 2 -14,35]. As discussed ear-
lier, ras activation is a frequent event in i/1 vivo mouse skin chemical 
carcinogenesis [5], and yet it is a relatively rare event in human skin 
carcinogenesis. The development of malignantly transformed 
mouse keratinocyte cell lines independent of H a-ras activation may 
help to identify important non-ras oncogenes. Whereas activated ras 
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has been proposed to complement other activated oncogenes in 
carcinogenesis [36,37], it is a very strongly acting oncogene in mOSt 
functional transformation assays and may mask the identification of 
other weaker complementing oncogenes. 
The acute experimental exposure of mouse skin to potent carcin_ 
ogens as compared to chronic environmental exposure of human 
skin to indigenous carci nogens may account for some of the onco_ 
gene activation frequency differences. The majority of environ_ 
mental human skin carcinogens are weak initiators, and the rela_ 
tively long latency of tumor formation suggests that carcinogen 
exposure is chronic rather than acute. Irl I/ilro chemical initiation 
studies in diploid human cells have demonstrated a significantly 
greater resistance to tumorigenic transformation than rodent cells. 
In fact, in transformed human keratinocytes, Boukamp el at h ave 
demonstrated that Ha-ras oncogene activation correlates better with 
growth potential than with malignancy [11] . Another report dem_ 
onstrated that ionizing radiation transformed immortalized human 
keratinocytes w ithout activatin g the Ha-ras oncogene [38]. In addi_ 
tion, Schweizer's laboratory has found that only one of 39 mouse 
squamous cell carcinomas induced by chronic ultraviolet (UV)b 
irradiation possessed an activated c-Ha-ras oncogene (data not 
shown). This further suggests that chronic exposure of mouse skin. 
to carcinogens resembles human carcinogenesis. Both human and 
animal models have shown that activa ted Ha-ras can be detected less 
frequently in malignant carcinomas than in their benign precursors 
[5,10]. It has been proposed elsewhere that environmental selection 
pressures may determine the spectrum of mutated oncogenes de_ 
tected [39] . Furthermore, recent studies indicate that the ability to 
detect c-Ha-ras mutations in mouse skin 30 d post-initiation corre_ 
lates with the potency of the carci nogen [40] . Quintanilla et at have 
reported that ras activation is a much more frequent occurrence 
during in villo mouse skin carcinogenesis than in i/I vitro studies [41 ]. 
These results suggest that ras activation may provide a greater selec_ 
tive advantage to initiated cells in mouse skin than in human skin. 
Although the present study suggests that DMBA induces genetic: 
alterations independent of c-Ha-ras mutations, it does not rule OUt 
defects that may interfere with the c-Ha-ras signal transduction 
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Figure 4. Northern blot analysis of c-Ha-ras in normal epidermal and 
tumor ce ll derivatives. Two hundred ninety-one normal parental and inde-
pendent normal clone 271c cells were grown in conditioned LC medium to 
enrich for proliferating basa l cells or in HC medium for 48 h before harvest-
ing to enrich for differentiating spinous cells. Tumor cell derivatives 
(291.09RAT, 291.03RAT, and 291.05RAT) were grown in He. The same 
blot was rehybridized with a 32P-labcled 7S probe to serve as an internal 
control for RNA loading. The positions of28S and 18S rRNAs are indicated. 
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pathway. Other defects have been associated with malignancy in 
the cloned keratinocyte model, in particular, changes in gene ex-
pression of the p53 tumor suppressor gene and the endogenous 
retrovirus-like sequence VL30 l24,42] . However, the events related 
to initiation in this model are still unknown. As DMBA may affect a 
significantly larger spectrum of genes during chemical carcinogen-
esis than has been suspected to date, the cloned keratinocyte model 
may prove useful in elucidating further genetic alterations in kerati-
nocyte transformation and may be pertinent to the etiology of non-
ras human skin tumors. Furthermore, because these cell lines lack 
c-Ha-ras mutations, future studies in this model system will provi~e 
a foc us for the identification of analogous functional genetic defects 
in human cancers of surface epithelia. 
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